Your browser doesn't support javascript.
loading
Macrocyclic Modalities Combining Peptide Epitopes and Natural Product Fragments.
Guéret, Stéphanie M; Thavam, Sasikala; Carbajo, Rodrigo J; Potowski, Marco; Larsson, Niklas; Dahl, Göran; Dellsén, Anita; Grossmann, Tom N; Plowright, Alleyn T; Valeur, Eric; Lemurell, Malin; Waldmann, Herbert.
Afiliação
  • Guéret SM; Department of Chemical Biology, AstraZeneca-Max Planck Institute Satellite Unit, Max-Planck-Institute of Molecular Physiology, 44227 Dortmund, Germany.
  • Thavam S; Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
  • Carbajo RJ; Department of Chemical Biology, Max-Planck-Institute of Molecular Physiology, 44227 Dortmund, Germany.
  • Potowski M; Chemistry, Oncology R&D, AstraZeneca, Cambridge CB2 0SL, United Kingdom.
  • Larsson N; Department of Chemical Biology, Max-Planck-Institute of Molecular Physiology, 44227 Dortmund, Germany.
  • Dahl G; Faculty of Chemistry and Chemical Biology, TU Dortmund University, 44227 Dortmund, Germany.
  • Dellsén A; Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
  • Grossmann TN; Structure, Biophysics & Fragment Based Lead Generation, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
  • Plowright AT; Mechanistic Biology & Profiling, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
  • Valeur E; Department of Chemistry and Pharmaceutical Sciences, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
  • Lemurell M; Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
  • Waldmann H; Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
J Am Chem Soc ; 142(10): 4904-4915, 2020 03 11.
Article em En | MEDLINE | ID: mdl-32058716
ABSTRACT
"Hot loop" protein segments have variable structure and conformation and contribute crucially to protein-protein interactions. We describe a new hot loop mimicking modality, termed PepNats, in which natural product (NP)-inspired structures are incorporated as conformation-determining and -restricting structural elements into macrocyclic hot loop-derived peptides. Macrocyclic PepNats representing hot loops of inducible nitric oxide synthase (iNOS) and human agouti-related protein (AGRP) were synthesized on solid support employing macrocyclization by imine formation and subsequent stereoselective 1,3-dipolar cycloaddition as key steps. PepNats derived from the iNOS DINNN hot loop and the AGRP RFF hot spot sequence yielded novel and potent ligands of the SPRY domain-containing SOCS box protein 2 (SPSB2) that binds to iNOS, and selective ligands for AGRP-binding melanocortin (MC) receptors. NP-inspired fragment absolute configuration determines the conformation of the peptide part responsible for binding. These results demonstrate that combination of NP-inspired scaffolds with peptidic epitopes enables identification of novel hot loop mimics with conformationally constrained and biologically relevant structure.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos Cíclicos / Receptores de Melanocortina / Proteínas Supressoras da Sinalização de Citocina Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Am Chem Soc Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos Cíclicos / Receptores de Melanocortina / Proteínas Supressoras da Sinalização de Citocina Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Am Chem Soc Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha